BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11022662)

  • 21. [Contrast sensitivity of several blindness-inducing eye diseases and the influence of tinted filter lens].
    Ding C; Sun B; Zheng Y
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):286-8. PubMed ID: 10451963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development of the Generation II as an aid for patients with retinitis pigmentosa and night blindness.
    Davidson B; Echols C; Jose R
    Am J Optom Physiol Opt; 1976 Feb; 53(2):88-94. PubMed ID: 1084695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case study of choroideremia highlighting differential diagnosis and management with Fresnel prism therapy.
    Tallman KB; Haskes C; Perlin RR
    J Am Optom Assoc; 1996 Jul; 67(7):421-9. PubMed ID: 8888868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older.
    Grover S; Fishman GA; Anderson RJ; Tozatti MS; Heckenlively JR; Weleber RG; Edwards AO; Brown J
    Ophthalmology; 1999 Sep; 106(9):1780-5. PubMed ID: 10485550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Veterans Affairs Multicenter Low Vision Enhancement System (LVES) study: clinical results. Report 1: effects of manual-focus LVES on visual acuity and contrast sensitivity.
    Ballinger R; Lalle P; Maino J; Stelmack J; Tallman K; Wacker R
    Optometry; 2000 Dec; 71(12):764-74. PubMed ID: 11145301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of retinitis pigmentosa and asteroid hyalosis: diagnosis and low vision management.
    Yin C
    J Am Optom Assoc; 1984 Oct; 55(10):773-6. PubMed ID: 6333446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes.
    Neidhardt J; Barthelmes D; Farahmand F; Fleischhauer JC; Berger W
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1630-5. PubMed ID: 16565402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual rehabilitation of patients with Stargardt's disease.
    Shah M; Zaman M; Khan MT; Khan MD
    J Coll Physicians Surg Pak; 2008 May; 18(5):294-8. PubMed ID: 18541085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual functions following recovery from non-arteritic central retinal artery occlusion.
    Landa E; Rehany U; Rumelt S
    Ophthalmic Surg Lasers Imaging; 2004; 35(2):103-8. PubMed ID: 15088819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of visual impairment and blindness in children attending seven schools for the blind in Myanmar.
    Muecke J; Hammerton M; Aung YY; Warrier S; Kong A; Morse A; Holmes M; Yapp M; Hamilton C; Selva D
    Ophthalmic Epidemiol; 2009; 16(6):370-7. PubMed ID: 19995202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual performance with night vision goggles after photorefractive keratectomy for myopia.
    Subramanian PS; O'Kane B; Stefanik R; Stevens J; Rabin J; Bauer RM; Bower KS
    Ophthalmology; 2003 Mar; 110(3):525-30. PubMed ID: 12623815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Component perimetry: a fast method to detect visual field defects caused by brain lesions.
    Bachmann G; Fahle M
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2870-86. PubMed ID: 10967040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longterm visual prognosis in Usher syndrome types 1 and 2.
    Sadeghi AM; Eriksson K; Kimberling WJ; Sjöström A; Möller C
    Acta Ophthalmol Scand; 2006 Aug; 84(4):537-44. PubMed ID: 16879578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of brimonidine tartrate 0.15% on night-vision difficulty and contrast testing after refractive surgery.
    Edwards JD; Burka JM; Bower KS; Stutzman RD; Sediq DA; Rabin JC
    J Cataract Refract Surg; 2008 Sep; 34(9):1538-41. PubMed ID: 18721716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Applicability of semi-automated kinetic perimetry (SKP) in the assessment of the visual field loss due to retinitis pigmentosa].
    Nowomiejska K; Paetzold J; Krapp E; Rejdak R; Zarnowski T; Zagórski Z; Schiefer U
    Klin Oczna; 2004; 106(3 Suppl):500-2. PubMed ID: 15636249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving nighttime mobility in persons with night blindness caused by retinitis pigmentosa: A comparison of two low-vision mobility devices.
    Mancil RM; Mancil GL; King E; Legault C; Munday J; Alfieri S; Nowakowski R; Blasch BB
    J Rehabil Res Dev; 2005; 42(4):471-86. PubMed ID: 16320143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel IMPDH1 mutation (Arg231Pro) in a family with a severe form of autosomal dominant retinitis pigmentosa.
    Grover S; Fishman GA; Stone EM
    Ophthalmology; 2004 Oct; 111(10):1910-6. PubMed ID: 15465556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cataract surgery in patients with retinitis pigmentosa].
    Schumacher S; Groh MJ; Naumann GO
    Klin Monbl Augenheilkd; 1998 Aug; 213(2):71-3. PubMed ID: 9782463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Registered blindness and low vision in Kuwait.
    Al-Merjan JI; Pandova MG; Al-Ghanim M; Al-Wayel A; Al-Mutairi S
    Ophthalmic Epidemiol; 2005 Aug; 12(4):251-7. PubMed ID: 16033746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Environmental variables and mobility performance in adults with low vision.
    Kuyk T; Elliott JL; Biehl J; Fuhr PS
    J Am Optom Assoc; 1996 Jul; 67(7):403-9. PubMed ID: 8888866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.